Table 1.
Patient | Age (Years)/Sex (M/F) | Primary Disease | eGFR | Coexisting Pathology in Nontumor Renal Parenchyma (% Diseased Cortical Area) |
---|---|---|---|---|
Normal PTEC (n = 5) | ||||
1 | 64/F | Clear cell RCC (Grade 2) | 72 | Nil |
2 | 58/M | Clear cell RCC (Grade 2) | 77 | Nil |
3 | 65/F | Clear cell RCC (Grade 2) | 81 | Nil |
4 | 61/M | Clear cell RCC (Grade 2) | 88 | Nil |
5 | 45/M | Clear cell RCC (Grade 2) | 90 | Nil |
Diseased PTEC (n = 5) | ||||
1 | 53/M | Chromophobe RCC | 75 | Glomerulosclerosis (5–10%) |
2 | 56/F | Chromophobe RCC | 90 | Glomerulosclerosis (5–10%) |
3 | 52/F | Clear cell RCC (Grade 2) | 90 | Arteriosclerosis (25–30%) |
4 | 60/M | Clear cell RCC (Grade 4) | 75 | Arteriosclerosis (10–20%) |
5 | 53/F | Chromophobe RCC | 76 | Tubular atrophy (10–20%) |